Characterization of clonal expansion in the CNS-restricted HIV reservoir using HIV SMRTcap, a novel single molecule assay providing simultaneous resolution of proviral genomes and integration sites
使用 HIV SMRTcap 表征 CNS 限制的 HIV 储存库中的克隆扩增,这是一种新型单分子检测,可同时解析原病毒基因组和整合位点
基本信息
- 批准号:9927047
- 负责人:
- 金额:$ 25.43万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2020
- 资助国家:美国
- 起止时间:2020-01-06 至 2020-07-31
- 项目状态:已结题
- 来源:
- 关键词:AIDS/HIV problemAutopsyBiological AssayBloodBrainCD4 Positive T LymphocytesCell Culture TechniquesCell LineCellsCentral Nervous System InfectionsChronicChronic Phase of DiseaseClonal ExpansionCustomDataDiseaseDivorceEventEvolutionFrequenciesGenerationsGenesGenetic TranscriptionGenomeGenomic DNAGenomicsHIVHIV InfectionsHIV-1ImmuneIndividualInfectionIntegronsIntronsKnowledgeLengthLymphoidLymphoid TissueMaintenanceMapsMediatingMethodologyMethodsMicrogliaMinorModelingMolecularMorbidity - disease rateMyeloid CellsNational NeuroAids Tissue ConsortiumNatureNeuraxisNeurocognitive DeficitNeurogliaPathologyPatientsPerformancePeripheralPeripheral Blood Mononuclear CellPlasmaPlayPopulationProliferatingProvirusesReproducibilityResolutionRestRoleSamplingSensitivity and SpecificitySourceSuggestionT memory cellTechnologyTestingTimeTissue SampleTissuesTropismVariantViralVirusVirus Replicationanalysis pipelineantiretroviral therapycell typedefined contributionexperimental studygenome integrityinnovationintegration sitemacrophagemembermemory CD4 T lymphocytemortalitynext generation sequencingnovelnovel strategiessample fixationself-renewalsingle moleculesingle molecule real time sequencingsite-specific integration
项目摘要
PROJECT SUMMARY
HIV infection of the CNS is an important source of morbidity and mortality in the chronic phase of disease,
despite availability of combination Antiretroviral Therapy (cART). Although early and wide use of cART has
reduced the occurrence of the more severe CNS pathologies, milder neurocognitive impairment is documented
in 20-50% of infected individuals. HIV invasion of the CNS is thought to occur within the first two weeks of
infection, where the virus infects perivascular macrophages and microglia, in addition to CD4+ central memory
T cells (TCCM), the primary infected cell in the periphery. The vast majority of the peripheral reservoir exists as
a very minor fraction of resting CD4+ TCCM and is thought to be maintained by the clonal expansion of latently
infected cells. Thus far, HIV reservoir characterization has focused on either identifying and classifying
integration sites or examining the integrity of the integrated proviral genomes, rarely both concurrently. Latency
studies are most often performed with patient-derived PBMC and may not adequately represent unique
features of tissue-specific reservoirs. In particular, studies of the CNS-specific HIV reservoir are few and limited
by sample access. The expanded cell tropism of brain HIV and the potential for low level, ongoing viral
replication are suggestive that reservoir dynamics may be dramatically different in the CNS compared to
plasma; however, the CNS reservoir remains poorly characterized with regard to proviral genome integrity,
integration sites, emergence and reservoir fixation of viral variants and the contribution of clonal expansion to
reservoir maintenance. Moreover, while CD4+ T memory cells can proliferate; terminally differentiated myeloid
and glial cells, the primary targets of HIV infection in the brain, are long-lived with limited capacity for self-
renewal. Standard methods for profiling HIV reservoirs are dependent on short read next generation
sequencing (NGS) technologies that require the examination of integration sites to be necessarily divorced
from the characterization of their associated proviral genomes. Short read NGS interrogation of integration
sites limits the mapability of the resulting data, which may further limit the identification of HIV integration sites;
while the use of single genome amplification (SGA) for proviral genome characterization is low throughput and
labor intensive. Here we have developed a novel, innovative HIV-specific molecular enrichment approach,
combined with single molecule sequencing (“HIV SMRTcap”), which resolves the complete HIV “integron”
(flanking integration sites and associated provirus) regardless of genomic context. We propose to apply this
technology to the characterization of HIV-infected CNS and lymphoid tissues, provided by the National
NeuroAIDS Tissue Consortium and including both viremic (n=3) and cART suppressed (n=3) patients, to
define, for the first time, the contribution of clonal expansion to the CNS-restricted reservoir. The results
generated by the proposed project will establish a novel method for directly interrogating the HIV integron and
will permit hypothesis generation surrounding tissue-restricted HIV persistence and reservoir maintenance.
项目概要
中枢神经系统的艾滋病毒感染是疾病慢性期发病率和死亡率的重要来源,
尽管可以使用联合抗逆转录病毒疗法 (cART) 尽管 cART 已得到早期和广泛的使用。
减少了更严重的中枢神经系统病变的发生,记录了更轻微的神经认知障碍
20-50% 的感染者中,HIV 入侵中枢神经系统被认为发生在感染后的前两周内。
感染,除了 CD4+ 中央记忆外,病毒还感染血管周围巨噬细胞和小胶质细胞
T细胞(TCCM),外周的主要感染细胞 绝大多数外周储存库存在。
静息 CD4+ TCCM 的一小部分,并且被认为是通过潜伏的克隆扩增来维持的
到目前为止,HIV 储存库特征主要集中在识别和分类上。
整合位点或检查整合原病毒基因组的完整性,很少同时进行。
研究最常使用患者来源的 PBMC 进行,可能不足以代表独特的情况
特别是,对 CNS 特异性 HIV 病毒库的研究很少且有限。
通过样本获取,脑部艾滋病毒的细胞向性扩大以及低水平、持续病毒的潜力。
复制表明,与中枢神经系统相比,储层动力学可能显着不同
血浆;然而,中枢神经系统储存库的前病毒基因组完整性仍不清楚,
病毒变体的整合位点、出现和储存库固定以及克隆扩增的贡献
此外,CD4+ T记忆细胞可以增殖终末分化的骨髓;
神经胶质细胞是大脑中 HIV 感染的主要目标,它们寿命较长,但自我修复能力有限。
HIV病毒储存库分析的标准方法依赖于下一代短读长。
要求检查整合位点必须分离的测序 (NGS) 技术
来自其相关原病毒基因组的短读 NGS 整合分析。
位点限制了结果数据的可映射性,这可能进一步限制艾滋病毒整合位点的识别;
而使用单基因组扩增 (SGA) 进行原病毒基因组表征的通量较低且
在这里,我们开发了一种新颖的、创新的艾滋病毒特异性分子富集方法,
结合单分子测序(“HIV SMRTcap”),解析完整的HIV“整合子”
(侧翼整合位点和相关原病毒)无论基因组背景如何,我们都建议应用这一点。
技术来表征艾滋病毒感染的中枢神经系统和淋巴组织,由国家提供
NeuroAIDS 组织联盟,包括病毒血症 (n=3) 和 cART 抑制 (n=3) 患者,以
首次定义克隆扩张对 CNS 限制性储存库的贡献。
拟议项目产生的结果将建立一种直接询问艾滋病毒整合子的新方法
将允许围绕组织限制的 HIV 持久性和储存库维护产生假设。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Melissa Laird Smith其他文献
Melissa Laird Smith的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Melissa Laird Smith', 18)}}的其他基金
Expanding regional capacity for single molecule sequencing through the purchase of the Sequel IIe sequencing system
通过购买 Sequel IIe 测序系统扩大区域单分子测序能力
- 批准号:
10632815 - 财政年份:2023
- 资助金额:
$ 25.43万 - 项目类别:
T-cell depletion and maintenance of the HIV-1 latent reservoir in distinct tissue compartments
T 细胞耗竭和不同组织区室中 HIV-1 潜伏库的维持
- 批准号:
10480980 - 财政年份:2022
- 资助金额:
$ 25.43万 - 项目类别:
T-cell depletion and maintenance of the HIV-1 latent reservoir in distinct tissue compartments
T 细胞耗竭和不同组织区室中 HIV-1 潜伏库的维持
- 批准号:
10591589 - 财政年份:2022
- 资助金额:
$ 25.43万 - 项目类别:
Characterization of clonal expansion in the CNS-restricted reservoir using HIV SMRTcap, a novel single molecule assay providing simultaneous resolution of proviral genomes and integration sites
使用 HIV SMRTcap 表征 CNS 限制性病毒库中的克隆扩增,这是一种新型单分子检测方法,可同时解析原病毒基因组和整合位点
- 批准号:
10320584 - 财政年份:2020
- 资助金额:
$ 25.43万 - 项目类别:
An ethnically diverse genomic reference resource for the human heavy and light chain immunoglobulin loci
人类重链和轻链免疫球蛋白基因座的种族多样化基因组参考资源
- 批准号:
10693395 - 财政年份:2018
- 资助金额:
$ 25.43万 - 项目类别:
An ethnically diverse genomic reference resource for the human heavy and light chain immunoglobulin loci
人类重链和轻链免疫球蛋白基因座的种族多样化基因组参考资源
- 批准号:
10202394 - 财政年份:2018
- 资助金额:
$ 25.43万 - 项目类别:
相似海外基金
Molecular Pathways of Innate Immunity and Substance Abuse in NeuroHIV
NeuroHIV 的先天免疫和药物滥用的分子途径
- 批准号:
10814534 - 财政年份:2023
- 资助金额:
$ 25.43万 - 项目类别:
Re-educating T cell-mediated immunity in SIV by modulating metabolic pathways
通过调节代谢途径重新训练 SIV 中 T 细胞介导的免疫
- 批准号:
10481246 - 财政年份:2022
- 资助金额:
$ 25.43万 - 项目类别:
Human/Animal Brain Chimera in drugs of abuse and HIV
滥用药物和艾滋病毒中的人/动物脑嵌合体
- 批准号:
10543385 - 财政年份:2022
- 资助金额:
$ 25.43万 - 项目类别:
Revealing the single cell determinants of brain relevant to persistent HIV infection and opioid use disorder
揭示与持续艾滋病毒感染和阿片类药物使用障碍相关的大脑单细胞决定因素
- 批准号:
10220611 - 财政年份:2021
- 资助金额:
$ 25.43万 - 项目类别: